Protocol No.: A051901

Title

Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma

Principal Investigator

Aulakh, Sonikpreet

Phase

I

Age Group

Adult

Applicable Disease Sites

Brain Cancer

Lymphoma

Participating Institution

Mary Babb Randolph Cancer Center

Contact

Kenna DeLancey

Study Coordinator

Email: kenna.delancey@hsc.wvu.edu

View on ClinicalTrials.gov